Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Amer El Ghali"'
Autor:
Amer El Ghali, Ashlan J. Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J. Holger, Esther Garcia, Michael P. Veve, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 2 (2024)
ABSTRACTMulti-drug resistant gram-negative bacteria present a significant global health threat. Cefiderocol (CFDC), a siderophore cephalosporin, has shown potential in combating this threat, but with the currently available data, its role in therapy
Externí odkaz:
https://doaj.org/article/dd8cbdc6b5e441c988efa50e6056b091
Autor:
Ashlan J. Kunz Coyne, Kyle Stamper, Amer El Ghali, Razieh Kebriaei, Biswajit Biswas, Melanie Wilson, Michael V. Deschenes, Truc T. Tran, Cesar A. Arias, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 4 (2023)
ABSTRACT Enterococcus faecium is a difficult-to-treat pathogen with emerging resistance to most clinically available antibiotics. Daptomycin (DAP) is the standard of care, but even high DAP doses (12 mg/kg body weight/day) failed to eradicate some va
Externí odkaz:
https://doaj.org/article/8dfc54dd9eb448adbe3bb0d313b8d146
Autor:
Razieh Kebriaei, Susan M. Lehman, Rahi M. Shah, Kyle C. Stamper, Ashlan J. Kunz Coyne, Dana Holger, Amer El Ghali, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Phage therapy has gained attention due to the spread of antibiotic-resistant bacteria and narrow pipeline of novel antibiotics. Phage cocktails are hypothesized to slow the overall development of resistance by challenging the bacteria with m
Externí odkaz:
https://doaj.org/article/6af1e70295ec474eb303d2a280649802
Autor:
Nicholas Rebold, Abdalhamid M. Lagnf, Sara Alosaimy, Dana J. Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J. Kunz Coyne, Amer El Ghali, Kaylee E. Caniff, Michael P. Veve, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 1 (2023)
ABSTRACT The Centers for Disease Control and Prevention (CDC) categorized carbapenem-resistant Enterobacterales (CRE) infections as an “urgent” health care threat requiring public attention and research. Certain patients with CRE infections may b
Externí odkaz:
https://doaj.org/article/bb0cc000590f459e8dd74d0e4f76ae4d
Autor:
Ashlan J. Kunz Coyne, Kyle Stamper, Razieh Kebriaei, Dana J. Holger, Amer El Ghali, Taylor Morrisette, Biswajit Biswas, Melanie Wilson, Michael V. Deschenes, Gregory S. Canfield, Breck A. Duerkop, Cesar A. Arias, Michael J. Rybak
Publikováno v:
Antibiotics, Vol 11, Iss 9, p 1175 (2022)
Multidrug-resistant (MDR) Enterococcus faecium is a challenging nosocomial pathogen known to colonize medical device surfaces and form biofilms. Bacterio (phages) may constitute an emerging anti-infective option for refractory, biofilm-mediated infec
Externí odkaz:
https://doaj.org/article/e296d9e2d0124deda1a74cc2f9037bc0
Autor:
Dana J. Holger, Nicholas S. Rebold, Sara Alosaimy, Taylor Morrisette, Abdalhamid Lagnf, Ana Christine Belza, Ashlan J. Kunz Coyne, Amer El Ghali, Michael P. Veve, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy. 11:1965-1980
Infections caused by multidrug-resistant (MDR), extensively drug-resistant (XDR), and difficult-to-treat (DTR) Pseudomonas aeruginosa are increasingly challenging to combat. Ceftolozane-tazobactam (C/T) is a novel β-lactam-β-lactamase inhibitor com
Culturally sensitive recommendations for the clinical pharmacist to engage the Arab American patient
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5:875-886
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
Publikováno v:
Infectious Diseases and Therapy. 11:661-682
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa isolates are frequent causes of serious nosocomial infections that may compromise the selection of antimicrobial therapy. The goal of this review is to summarize re
Autor:
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael J Rybak
Publikováno v:
Open Forum Infectious Diseases. 10
Background Limited data suggest that serious infections caused by Enterobacterales with a moderate to high risk of clinically significant AmpC production can be successfully treated with cefepime if the cefepime minimum inhibitory concentration (MIC)